Related Experiment Video
Updated: Jun 16, 2026

Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Rapid immunohistochemistry for intraoperative differentiation between high-grade gliomas and primary central nervous
Takahiro Ono1, Hiroaki Shimizu2,3, Yuko Hiroshima4
1Department of Neurosurgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, 010-8543, Japan. t.ono@med.akita-u.ac.jp.
Abstract:
Rapid intraoperative differentiation between high-grade gliomas (HGGs) and primary central nervous system lymphomas (PCNSLs) is critical because surgical strategies and adjuvant therapies differ substantially. We conducted a multicenter prospective observational study to evaluate rapid immunohistochemistry (R-IHC) on frozen sections using alternating current electric field mixing. Forty-eight adults with newly suspected malignant intra-axial brain tumors underwent tumor resection or biopsy with intraoperative frozen section consultation. The prespecified primary endpoint was antibody level concordance between R-IHC and conventional immunohistochemistry on permanent formalin-fixed, paraffin-embedded sections. Intraoperative diagnostic performance using hematoxylin and eosin (HE) alone versus HE plus R-IHC was assessed descriptively. Final diagnoses were HGG in 37 patients, PCNSL in 8, and other lesions in 3. For HGG, HE-based intraoperative diagnosis showed 91.9% sensitivity and 90.9% specificity, whereas HE plus R-IHC showed 100% sensitivity in this cohort and unchanged specificity (90.9%). CD20 showed complete concordance between rapid and permanent staining. Ki-67 labeling indices were strongly correlated between the two methods (Spearman r = 0.821). Therefore, R-IHC provides reliable immunostaining results on frozen sections and may serve as a practical adjunct to HE-based intraoperative differentiation between HGGs and PCNSLs in this diagnostic setting.

